Stay updated with breaking news from Arnab Basu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kromek receives $1.6m in advanced imaging orders Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that it has secured four orders totalling $1.63m in the advanced imaging segment. The orders,...
Russian attacks on nuclear power stations have made the risks even greater
Arnab Basu joins other technology bosses ‘frustrated’ with London’s small-cap market after Kromek’s share price dropped more than 90 per cent since 2013
The MoU signed with West Bengal government to provide entrepreneurs 100 Million Learners Course free of cost also found mention at the event
Arnab Basu, MD, MPH, FACP, discusses molecular residual disease-guided adjuvant therapy in patients with renal cell carcinoma, highlighting the rationale and goals of the MRD gate RCC clinical trial.